Literature DB >> 8381356

Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I.

P Y Cheng1, D Wu, J Decena, Y Soong, S McCabe, H H Szeto.   

Abstract

[D-Ala2]deltorphin I effects on fetal respiratory activity was characterized to determine the role delta-opioid receptors play in modulating fetal respiratory activity. [D-Ala2]deltorphin I, infused at 0.3 or 100 micrograms/h, intracerebroventricularly (i.c.v.), stimulated fetal respiratory activity without changing blood pH, PCO2 or PO2. Stimulation by 0.3 micrograms/h, but not 100 micrograms/h, was blocked by i.c.v. infusion of the delta-opioid receptor antagonist, naltrindole. Stimulation by 100 micrograms/h was blocked by the mu 1-opioid receptor antagonist naloxonazine. These data suggest stimulation of fetal respiratory activity by 0.3 micrograms/h [D-Ala2]deltorphin I are mediated specifically through delta-opioid receptors; while [D-Ala2]deltorphin I at 100 micrograms/h is no longer selective for the delta-opioid receptor, and the stimulation may be mediated through the mu 1-opioid receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381356     DOI: 10.1016/0014-2999(93)90413-c

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors.

Authors:  Stephen M Johnson; Sara M F Turner
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

2.  Activation of peripheral delta-opioid receptors leads to anti-hyperalgesic responses in the masseter muscle of male and female rats.

Authors:  J L Saloman; K Y Niu; J Y Ro
Journal:  Neuroscience       Date:  2011-06-06       Impact factor: 3.590

3.  Differentiation of receptor subtypes by thermodynamic analysis: application to opioid delta receptors.

Authors:  K D Wild; F Porreca; H I Yamamura; R B Raffa
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

4.  Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082).

Authors:  Mario D Aceto; Everette L May; Louis S Harris; Edward R Bowman; Charles D Cook
Journal:  Eur J Pharmacol       Date:  2007-03-19       Impact factor: 4.432

Review 5.  Opioid peptide-derived analgesics.

Authors:  Peter W Schiller
Journal:  AAPS J       Date:  2005-10-14       Impact factor: 4.009

6.  Analgesia targeting IB4-positive neurons in cancer-induced mechanical hypersensitivity.

Authors:  Yi Ye; Dongmin Dang; Chi T Viet; John C Dolan; Brian L Schmidt
Journal:  J Pain       Date:  2012-04-05       Impact factor: 5.820

7.  Prenatal behavior of the C57BL/6J mouse: a promising model for human fetal movement during early to mid-gestation.

Authors:  Gale A Kleven; April E Ronca
Journal:  Dev Psychobiol       Date:  2009-01       Impact factor: 3.038

8.  P2X₃ and TRPV1 functionally interact and mediate sensitization of trigeminal sensory neurons.

Authors:  J L Saloman; M-K Chung; J Y Ro
Journal:  Neuroscience       Date:  2012-11-29       Impact factor: 3.590

Review 9.  Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery.

Authors:  Yeon Sun Lee
Journal:  Biomolecules       Date:  2022-09-05

Review 10.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.